HYFT Key Statistics, Chart & Performance
The current stock price of HYFT is 1.7 USD. In the past month the price decreased by -3.41%.
HYFT Latest News, Press Relases and Analysis
HYFT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.89 | 217.89B | ||
| DHR | DANAHER CORP | 29.94 | 163.05B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 185.99 | 56.52B | ||
| A | AGILENT TECHNOLOGIES INC | 24.8 | 39.23B | ||
| IQV | IQVIA HOLDINGS INC | 19.36 | 38.34B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.81 | 28.90B | ||
| WAT | WATERS CORP | 30.17 | 22.81B | ||
| ILMN | ILLUMINA INC | 31.24 | 20.81B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.25 | 19.96B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.84 | 16.05B | ||
| TEM | TEMPUS AI INC | N/A | 11.51B | ||
| RVTY | REVVITY INC | 20.37 | 11.06B |
Related stock screener links
About HYFT
Company Profile
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Company Info
MINDWALK HOLDINGS CORP
Industrious, 823 Congress Ave, Suite 300
Austin TEXAS US
Employees: 102
Phone: 16048060626
MINDWALK HOLDINGS CORP / HYFT FAQ
What does HYFT do?
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
What is the stock price of MINDWALK HOLDINGS CORP today?
The current stock price of HYFT is 1.7 USD. The price decreased by -1.73% in the last trading session.
Does HYFT stock pay dividends?
HYFT does not pay a dividend.
What is the ChartMill rating of MINDWALK HOLDINGS CORP stock?
HYFT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists HYFT stock?
HYFT stock is listed on the Nasdaq exchange.
What sector and industry does MINDWALK HOLDINGS CORP belong to?
MINDWALK HOLDINGS CORP (HYFT) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the PE ratio for HYFT stock?
MINDWALK HOLDINGS CORP (HYFT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.14).
HYFT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to HYFT.
HYFT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HYFT. HYFT has a bad profitability rating. Also its financial health evaluation is rather negative.
HYFT Financial Highlights
Over the last trailing twelve months HYFT reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 58.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -114.31% | ||
| ROE | -168.52% | ||
| Debt/Equity | 0.18 |
HYFT Forecast & Estimates
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 140% is expected in the next year compared to the current price of 1.7.
For the next year, analysts expect an EPS growth of 38.8% and a revenue growth -33.14% for HYFT